Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Jerry Mendell

Neurology Columbus, OH Medical Doctor

NPI 1235123258 CMS profile 455402

700 Childrens Dr, Rm Wa3024, Columbus, OH 43205

Open in the dashboard

General payments

$314,866

378 records reported · program years 2019–2024

Research payments

$5,799

Paid to them · 25 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,165,742 paid to institutions, not to them · program years 2019–2024

Through program year 2024, Jerry Mendell of Columbus, OH is reported in the CMS Open Payments database as having received $314,866 across 378 general payments and $5,799 in research payments paid to them. Separately, studies naming them as principal investigator received $11,165,742 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $1,376 1
2024 Research $1,252 8
2023 General $115,043 64
2023 Research $2,610 11
2022 General $45,073 47
2021 General $26,552 34
2021 Research $1,937 6
2020 General $54,863 98
2019 General $71,958 134

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jerry Mendell
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Jerry Mendell were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Jerry Mendell Neurology median Middle half National median
2019 $71,958 $474 $118–$2,177 $163
2020 $54,863 $367 $82–$2,309 $114
2021 $26,552 $438 $104–$2,547 $132
2022 $45,073 $442 $103–$2,388 $149
2023 $115,043 $464 $119–$2,312 $160
2024 $1,376 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Sarepta Therapeutics, Inc. $173,367 106 payments
  2. AveXis $120,387 264 payments
  3. Vertex Pharmaceuticals Incorporated $20,682 6 payments
  4. F. Hoffmann-La Roche AG $430 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $166,386 34 payments
  2. Education $87,519 234 payments
  3. Travel and Lodging $27,030 48 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,443 28 payments
  5. Honoraria $5,400 2 payments
  6. Food and Beverage $2,087 32 payments
Products named General payments · program years 2019–2024
  1. ZOLGENSMA Gene Therapy $114,511 262 payments
  2. Exondys 51 $15,547 16 payments
  3. ZOLGENSMA Neurology $1,376 1 payment
  4. Amondys 45 $9 1 payment
  5. Vyondys 53 $9 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. F. Hoffmann-La Roche AG $5,371 23 payments
  2. Sarepta Therapeutics, Inc. $428 2 payments

Records

403 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record